Literature DB >> 10028077

Newly recognized focus of La Crosse encephalitis in Tennessee.

T F Jones1, A S Craig, R S Nasci, L E Patterson, P C Erwin, R R Gerhardt, X T Ussery, W Schaffner.   

Abstract

La Crosse virus is a mosquito-borne arbovirus that causes encephalitis in children. Only nine cases were reported in Tennessee during the 33-year period from 1964-1996. We investigated a cluster of La Crosse encephalitis cases in eastern Tennessee in 1997. Medical records of all suspected cases of La Crosse virus infection at a pediatric referral hospital were reviewed, and surveillance was enhanced in the region. Previous unreported cases were identified by surveying 20 hospitals in the surrounding 16 counties. Mosquito eggs were collected from five sites. Ten cases of La Crosse encephalitis were serologically confirmed. None of the patients had been discharged from hospitals in the region with diagnosed La Crosse encephalitis in the preceding 5 years. Aedes triseriatus and Aedes albopictus were collected at the case sites; none of the mosquitos had detectable La Crosse virus. This cluster may represent an extension of a recently identified endemic focus of La Crosse virus infection in West Virginia.

Entities:  

Mesh：

Year:  1999        PMID： 10028077     DOI： 10.1086/515087

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  14 in total

1.  A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.

Authors:  R S Bennett; A K Gresko; J T Nelson; B R Murphy; S S Whitehead
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  Host-feeding patterns of Aedes albopictus (Diptera: Culicidae) in relation to availability of human and domestic animals in suburban landscapes of central North Carolina.

Authors:  Stephanie L Richards; Loganathan Ponnusamy; Thomas R Unnasch; Hassan K Hassan; Charles S Apperson
Journal:  J Med Entomol       Date:  2006-05       Impact factor: 2.278

3.  La Crosse virus infection alters blood feeding behavior in Aedes triseriatus and Aedes albopictus (Diptera: Culicidae).

Authors:  Bryan T Jackson; Carlyle C Brewster; Sally L Paulson
Journal:  J Med Entomol       Date:  2012-11       Impact factor: 2.278

Review 4.  Neuroinvasive arboviral disease in the United States: 2003 to 2012.

Authors:  James T Gaensbauer; Nicole P Lindsey; Kevin Messacar; J Erin Staples; Marc Fischer
Journal:  Pediatrics       Date:  2014-08-11       Impact factor: 7.124

Review 5.  Impacts of climate, land use, and biological invasion on the ecology of immature Aedes mosquitoes: implications for La Crosse emergence.

Authors:  Paul T Leisnham; Steven A Juliano
Journal:  Ecohealth       Date:  2012-06-13       Impact factor: 3.184

Review 6.  Innate immune response to La Crosse virus infection.

Authors:  Katherine G Taylor; Karin E Peterson
Journal:  J Neurovirol       Date:  2013-07-12       Impact factor: 2.643

7.  The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007.

Authors:  Andrew D Haddow; Danae Bixler; Agricola Odoi
Journal:  BMC Infect Dis       Date:  2011-01-26       Impact factor: 3.090

8.  The demographic and socioeconomic factors predictive for populations at high-risk for La Crosse virus infection in West Virginia.

Authors:  Andrew D Haddow; Danae Bixler; Amy J Schuh
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

9.  First isolation of La Crosse virus from naturally infected Aedes albopictus.

Authors:  R R Gerhardt; K L Gottfried; C S Apperson; B S Davis; P C Erwin; A B Smith; N A Panella; E E Powell; R S Nasci
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

10.  The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007.

Authors:  Andrew D Haddow; Agricola Odoi
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.